Brightworth’s Allergan plc AGN Stock Holding History

Brightworth’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-951	Closed	-$231K	–	133
2017 Q2	$231K	Hold	951	–	–	0.13%	29
2017 Q1	$227K	Sell	951 -94	-9%	-$21.9K	0.12%	30
2016 Q4	$219K	Buy	+1,045	New	+$216K	0.12%	36

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Brightworth's AGN Position: Q3 2017 in Review

Brightworth sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 951 shares — an estimated $231K sold.

Brightworth first reported a position in AGN in Q4 2016 and held it in 3 quarters. The position peaked at $231K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Brightworth reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Brightworth sold 951 Allergan plc shares in Q3 2017, an estimated $231K.
Brightworth first reported a position in Allergan plc in Q4 2016 and held it in 3 quarters.
Brightworth's Allergan plc position peaked at $231K in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Brightworth's 13F filing for Q3 2017, filed 30 Oct 2017.